Minoxidil

Minoxidil was developed to treat severe high blood pressure. It works by relaxing the smooth muscle of the arteries, and the CPSC rulemaking describes the effects plainly: “The most prominent effects from therapeutic ingestion of minoxidil are increased heart rate, increased cardiac output and decreased blood pressure.”

Then there was a side effect. The same document notes that “repeated ingestion over several months can produce hypertrichosis”, meaning overstimulated hair growth. A problem for a hypertension patient, and a product for everybody else.

Why it sits apart from the rest of the shelf

This is the point of the page.

FDA “approved the sale of topical minoxidil as an over-the-counter (“OTC”) drug available without a prescription” in February 1996. It had been available on prescription since 1988. It went through a drug approval: an indication, a studied concentration, a defined population and a documented safety profile.

Almost nothing else in the category did. The regulation covering over-the-counter topical products sold as hair growers states that “all labeling claims for OTC hair grower and hair loss prevention drug products for external use are either false, misleading, or unsupported by scientific data”.

Two aisles of the same shop, one product that cleared approval and a great many that the regulator has characterised in those terms. From the front of a pack they look identical, because the front of a pack is marketing and the drug facts panel is not.

That distinction, rather than anything about minoxidil itself, is the most useful thing a reader in this category can take away, and it is the argument of the hair loss cluster.

What the packaging rule tells you

Preparations containing more than 14 milligrams of minoxidil in a single package require child-resistant packaging, under the Poison Prevention Packaging Act, effective from 1999.

That is not a warning about using it. It is a statement about swallowing it, and specifically about a small child swallowing it, in a product that is a liquid in a bathroom rather than a tablet in a cabinet. A drug that lowers blood pressure is a serious thing for a toddler to drink.

Worth knowing because it is the clearest available signal that this is pharmacologically active. Shampoo does not come with a child-resistant cap.

The honest picture of what it does

It works for some people, partially, for as long as they keep using it. Stopping returns hair to where it would have been, because it does not change the underlying process.

The early weeks can involve increased shedding, which is expected and is the mechanism rather than a failure. It is more effective at maintaining than at regrowing, and more effective earlier than later.

The liquid formulation is usually in Propylene glycol, which is the most common cause of scalp irritation with this product. Foam formulations generally omit it, which is a real reason to switch rather than a marketing distinction.

Pregnancy

Minoxidil is not recommended in pregnancy or while breastfeeding. This is one of the few places on this site where the answer is a flat one rather than a discussion of evidence, and it belongs with a doctor rather than with a label.

Reading a hair product for it

If a product contains minoxidil it carries a drug facts panel, because it must. If there is no drug facts panel, there is no approved active, whatever the front says about density and thickness.

That is a fast and reliable test, and it works across the whole category. Products in the same aisle built on Biotin, caffeine or peptides are cosmetics, and a cosmetic making a growth claim is exactly what the regulation is describing.